NCT01094171View on ClinicalTrials.gov

Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia

PHASE4CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

December 3, 2010

Primary Completion Date

October 27, 2012

Study Completion Date

October 27, 2012

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

Poliorix TM

Intramuscular administration, 3 doses

BIOLOGICAL

Infanrix TM

Intramuscular administration, 3 doses

Trial Locations (2)

620085

GSK Investigational Site, Yekaterinburg

656056

GSK Investigational Site, Barnaul

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01094171 - Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia | Biotech Hunter | Biotech Hunter